Evidence map›Paper›PMID 42840123›Full record

ArticleEJHaem2026

Successful Pregnancy After Planned Pregnancy-Oriented TKI Interruption and Embryo Transfer Following Ponatinib Re-Consolidation in Chronic-Phase Chronic Myeloid Leukemia.

Fumisato Takagi, Takaaki Ono, Yuma Nagai, Yuki Nagai, Yusuke Yokota, Aoi Warashina, Takumi Okuwa, Motoyasu Fukuyo, Katsumi Koyauchi, Yujiro Ito and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fumisato TakagiDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Takaaki OnoDepartment of Transfusion and Cell Therapy Hamamatsu University School of Medicine Hamamatsu Japan.
Yuma NagaiDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Yuki NagaiDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Yusuke YokotaDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Aoi WarashinaDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Takumi OkuwaDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Motoyasu FukuyoDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Katsumi KoyauchiDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Yujiro ItoDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Satoshi UchiyamaDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Tomonari TakemuraDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
Yasuyuki NagataDivision of Hematology Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pregnancy after unsuccessful treatment-free remission (TFR) in chronic-phase chronic myeloid leukemia (CP-CML) remains challenging. Case Presentation: A woman lost major molecular response (MMR) after stopping a Conclusion: Sequential ponatinib re-consolidation and ART may enable planned TKI interruption for pregnancy. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Identifiers

PMID42840123
PMCPMC13638774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.